Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating encouraging results in the control of type 2 diabetes. This artificial peptide resembles the actions of naturally produced GLP-1, a hormone that plays a crucial role in regulating blood glucose levels. By enhancing GLP-1 receptors in the pancreas, Retasturtide increases